Clinical Trial Update: Phase III Trial of Topical Formulation of Sirolimus to Skin Lesions in Patients With Tuberous Sclerosis Complex (TSC) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating topical sirolimus for skin lesions in tuberous sclerosis complex has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberous Sclerosis Complex

Drugs mentioned

• Sirolimus (Sirolimus)

Snippet

Sponsor: Nobelpharma | Conditions: Tuberous Sclerosis, Angiofibroma | Phase 3 | Status: COMPLETED